Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 8:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 385–403 of 403 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Normal Weight Clear all

Conditions: Obesity
Interventions: Standard of Care, Time Restricted Eating; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Juvenile Idiopathic Arthritis, Rheumatoid Arthritis, Obesity
Interventions: Etanercept Optimal dosing; Drug
Lead sponsor: Duke University; Other
Eligibility: 2 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Early Stage Breast Cancer (Stage 0-III)
Interventions: Exercise Regimen; Other
Lead sponsor: Nevada Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Obesity
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2014
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Adult Supratentorial Primitive Neuroectodermal Tumor (PNET), Ewing Sarcoma of Bone, Extraosseous Ewing Sarcoma, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: fluorine F 18 fluorothymidine, fludeoxyglucose F 18, positron emission tomography, diffusion-weighted magnetic resonance imaging, laboratory biomarker analysis; Drug · Radiation · Procedure + 1 more
Lead sponsor: Mayo Clinic; Other
Eligibility: 7 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: PreDiabetes, Obesity
Interventions: Mango, Placebo; Other
Lead sponsor: Florida State University; Other
Eligibility: 50 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Psoriasis, Obesity
Interventions: Weight Loss; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: 20 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Breast Cancer
Interventions: Tailored Lifestyle Intervention (TLI), Commercial Weight Loss Program (CWLP); Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 65 Years · Female only
Enrollment: 87 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 2
States / cities: Gainesville, Florida • Jacksonville, Florida

Conditions: Metastatic Disease to Bone, Metastatic Disease to Soft Tissue
Interventions: MRI with IVIM DW-MRI, Blood draw; Device · Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity, Hypertension, Diabetes-Mellitus, Non-Insulin Dependent
Interventions: Not listed
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 21 Years to 65 Years
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hyperlipidemia
Interventions: Standard Process 21 Day Purification Program (SPPP); Other
Lead sponsor: Logan College of Chiropractic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Chesterfield, Missouri

Conditions: Morbid Obesity
Interventions: Gastrisail; Device
Lead sponsor: Maimonides Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Tissue Oxygenation
Interventions: Resonance Raman Spectroscopy (RPS); Device
Lead sponsor: University of Florida; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Glucose Intolerance, Overweight and Obesity, Drug Effect, Adiposity
Interventions: Cyanocobalamin, Dulaglutide; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 50 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Obesity, Mycoses
Interventions: Anidulafungin; Drug
Lead sponsor: Texas Tech University Health Sciences Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Obesity
Interventions: CP-945,598; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Anaheim, California • Miami, Florida

Conditions: Insulin Resistance, Obesity, Metabolic Syndrome
Interventions: weight loss, thiazolidinedione; Behavioral · Drug
Lead sponsor: Stanford University; Other
Eligibility: 30 Years to 65 Years
Enrollment: 88 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: Stanford, California

Conditions: Cancer Survivor, No Evidence of Disease, Obesity, Overweight, Prostate Carcinoma, Sedentary Lifestyle, Stage I Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
Interventions: Exercise Intervention, Laboratory Biomarker Analysis, Polar heart rate monitor, Quality-of-Life Assessment, Questionnaire Administration; Behavioral · Other
Lead sponsor: University of Southern California; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Search by objective public record fields.

Effect of Time-restricted Eating on Catecholamine-sensitivity of Adipose Tissue in Obese Adults

Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis

Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise Laboratory

Body Heat Content and Dissipation in Obese and Normal Weight Adults

18F-FLT Positron Emission Tomography and Diffusion-Weighted Magnetic Resonance Imaging in Planning Surgery and Radiation Therapy and Measuring Response in Patients With Newly Diagnosed Ewing Sarcoma

Effect of Mango Consumption on Individuals with Pre-diabetes

The Effect of Weight Loss on Psoriasis Area Severity Index in Adult Psoriasis Patients

Microenvironment of Adipose Tissue in Endocannabinoid System

My Lifestyle Intervention of Food and Exercise

Detection of Acid Sphingomyelinase/Ceramide Pathway Activation in Radiotherapy Patients Using Intravoxel Incoherent Motion (IVIM) Diffusion-weighted Magnetic Resonance Imaging and Serum Biomarkers

Methods for Measuring Insulin Sensitivity

Standard Process 21 Day Purification Program Project

Transmitted Light Tissue Thickness Analysis (TiLTT)

Tissue Oxygen Deprivation as Detected With Raman in Association With Umbilical Artery Catheters

GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response

Effect of Weight and/or Obesity on Anidulafungin Drug Concentrations

Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

Integrating the Genetic and Metabolic Faces of Obesity

Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors